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Lactate Production During Maximal and Submaximal Exercise in 
Patients With Chronic Heart Failure 
KARL T. WEBER, MD, FACC, JOSEPH S. JANICKI, PHD 
Chicago, Illinois 
In patients with chronic heart failure whose cardiac out•
put response to exercise is impaired, determination of 
anaerobic threshold may provide a useful and objective 
approach to grade the severity of heart failure. In such 
patients performing upright trelldmill exercise to ex•
haustion, this study examined the reproducibility of the 
response of cardiac output and mixed venous lactate 
concentration when the exercise test was repeated the 
same or next day, the nature of this response after rest 
and exercise cardiac output levels were augmented by 
the cardiotonic agent amrinone and the response of lac•
tate during symptom-limited submaximal exercise per•
formed at either aerobic or anaerobic levels of work for 
each patient. 
Findings were: 1) the response of cardiac output and 
It is well known that at moderate and severe levels of mus•
cular work, blood lactate concentration is increased (1-3), 
particularly in the venous blood draining working muscle 
(4,5). This increase in venous lactate concentration, which 
indicates the onset of lactate production and presumably a 
major shift to anaerobic metabolism in working skeletal 
muscle, was termed the anaerobic threshold by Wasserman 
and McIlroy (6). We (7) and others (8) suggested that in 
patients with chronic heart failure, whose cardiac output 
response to incremental exercise is impaired in proportion 
to the severity of pump dysfunction, determination of the 
anaerobic threshold would be a useful clinical tool to grade 
the severity of heart failure. It is unclear, however, whether 
the response of venous lactate and cardiac output in such 
patients is reproducible, whether changes in oxygen delivery 
would alter the lactate response and whether venous lactate 
would also increase during prolonged submaximal exercise. 
Accordingly, the present study was undertaken in patients 
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mixed venous lactate was reproducible (p < 0.05) when 
assessed either the same or the next day; 2) when exercise 
cardiac output was increased (p < 0.05) by oral amri•
none therapy, the increase in lactate was delayed (p < 
0.05) to higher levels of muscular work and this was not 
true when cardiac output was unchanged; and 3) only 
submaximal anaerobic exercise was symptom limited and 
associated with an increase in lactate concentration. Thus, 
the lactate response and anaerobic threshold determi•
nation should prove useful to assess the severity of chronic 
stable heart failure and its response to pharmacologic 
intervention. The submaximal anaerobic exercise test 
may provide additional insights into the effort intoler•
ance these patients experience. 
(J Am Coli CardioI1985;6:717-24) 
with chronic heart failure of varying severity and diverse 
etiology. Its purpose was to address the following issues: 
I) the reproducibility of the response of cardiac output and 
mixed venous lactate concentration during a standardized, 
incremental treadmill exercise protocol repeated the same 
or next day; 2) the nature of the response after oxygen 
delivery was enhanced pharmacologically by the cardiotonic 
agent amrinone; and 3) the response of mixed venous lactate 
during submaximal exercise performed at either aerobic or 
anaerobic levels of work for each patient. 
Methods 
Study patients. Sixty-three patients (37 men and 26 
women) ranging in age from 15 to 78 years (mean 53 ± 
12) and having chronic stable heart failure were included 
in this study. The etiologic basis of their heart disease in•
cluded idiopathic congestive cardiomyopathy (36 patients); 
ischemic heart disease with previously documented myo•
cardial infarction by clinical, electrocardiographic or an•
giographic criteria (11 patients) and chronic mitral or aortic 
valve regurgitation (16 patients). The functional status of 
these patients, representing New York Heart Association 
clinical classes II to IV, had been stable for at least 2 months 
before exercise testing. All were outpatients and were main-
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tained on digitalis and diuretic drugs for at least 6 months. 
Nine patients had chronic atrial fibrillation; the remainder 
were in sinus rhythm. All patients had cardiac enlargement 
by examination and as estimated by a cardiothoracic ratio 
of greater than 50% on standard chest roentgenogram. 
Patients were excluded if they had angina pectoris re•
quiring treatment with antianginal medications other than 
occasional use of nitroglycerin, exercise-induced angina, 
ventricular arrhythmias or significant aortic stenosis or air•
way disease by standard pulmonary function tests. 
Patient selection. The data obtained from all patients 
whom we have evaluated over the years with invasive hemo•
dynamic monitoring during exercise testing are stored in 
our Cardio-Pulmonary Exercise Laboratory data bank. Pa•
tients included in this report were selected from that bank 
on the basis of I) the completion of all of the required 
exercise tests (analyzed later in this report), 2) complete 
data files, 3) the severity of disease represented by the spec•
trum (classes A to D) of heart failure addressed by the 
analysis, and 4) the etiologic basis of disease (ischemic, 
myopathic or valvular incompetence as just described). 
The initial selection of patients who reexercised on the 
afternoon of the test day were based solely on the patients' 
willingness to do so, their successful completion of the 
morning test and availability of all necessary data (see later) 
for comparison and determination of reproducibility. The 
same was true of the cohort performing endurance exercise; 
however, these patients had to have first completed the 
incremental test. Patients receiving oral amrinone were se•
lected because they had, on the etiologic basis described, 
more advanced chronic heart failure that was unresponsive 
to medical therapy, including digoxin and diuretic drugs. 
Incremental exercise. Each patient gave informed writ•
ten consent to participate in an experimental protocol ap•
proved by the hospital's review board. On the morning of 
the study and 2 to 3 hours after a simple liquid breakfast, 
a triple lumen flotation catheter was advanced into the pul•
monary artery through an antecubital vein. Patients were 
then taken to the air-conditioned (21 to 23°C) exercise fa•
cility where their hemodynamic response to incremental 
treadmill exercise was monitored together with the breath 
by breath respiratory gas exchange, air flow, mixed venous 
lactate concentration and oxygen saturation responses. 
The incremental treadmill exercise program consisted of 
2 minute stages of progressive work. The exercise protocol, 
reported elsewhere (9), was designed to accommodate the 
wide range of aerobic capacities seen in patients with chronic 
heart failure. Each patient had previously performed one or 
more exercise tests and therefore was familiar with the tread•
mill protocol. As previously reported (7), intravascular pres•
sures, cuff blood pressure, a modified lead V 5 electrocar•
diogram and heart rate were monitored at rest, throughout 
exercise and during recovery. Cardiac output was deter•
mined by the Fick principle from the oxygen uptake (V02 , 
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mllmin) measurement and the calculation of the arteriove•
nous oxygen difference. 
The data acquisition protocol was as follows: hemody•
namic data, mixed venous lactate concentration, oxygen 
saturation, respiratory gas exchange and air flow data were 
obtained with the patient standing quietly for several min•
utes. During exercise, end-expiratory wedge pressure was 
obtained at the midpoint of each stage of exercise while 
mixed venous blood was sampled during the last minute of 
each stage. 
Patients were exercised to exhaustion and to their max•
imal oxygen uptake (V02 max), as defined by V02 changing 
less than I mllmin per kg despite an increment in work load 
that was sustained for 30 seconds or longer. As previously 
reported (7), we grade the severity of chronic heart failure 
according to V02 max as follows: greater than 20 mllmin 
per kg represents no to mild heart failure (class A, 5 pa•
tients); 16 to 20 mllmin per kg, mild to moderate failure 
(class B, 7 patients); 10 to 15 mllmin per kg, moderate to 
severe failure (class C, 25 patients) and less than 10 mllmin 
per kg, severe failure (class D,. 26 patients). 
Mixed venous blood was immediately analyzedfor lactate 
concentration (Yellow Springs YSI 23L). This technique 
was validated by its comparison with a standard spectro•
photometric method (10). The normal lactate value at rest 
for this laboratory was 7.24 ± 1.63 mg/lOO ml. The onset 
of lactate production by exercising skeletal muscle was con•
sidered to be present when mixed venous lactate concen•
tration exceeded 12 mgllOO ml (average value at rest ± 2 
SD). For the analysis of anaerobic threshold for each ex•
ercise class, the V02 corresponding to this increase in mixed 
venous lactate was selected (Fig. 1). 
Reproducibility. The response of hemodynamics, mixed 
venous lactate and V02 to incremental exercise was deter•
mined in all 63 patients. After a recovery period of at least 
2 hours, eight of these patients were reexercised. The pro•
tocol for the same day exercise study was similar to that 
outlined. In addition, 20 other patients were reexercised the 
next day after they had received oral amrinone (1.64 ± 
0.18 mg/kg body weight every 8 hours for four doses), a 
cardiotonic agent with positive inotropic and vasodilator 
properties. 
Submaximal endurance exercise. After anaerobic 
threshold and V02 max were determined, nine other patients 
were reexercised after a recovery period of I or more hours. 
In these patients, the second exercise test consisted of sub•
maximal endurance exercise at a work load that was selected 
from the incremental test as representing aerobic (five pa•
tients) or anaerobic (four patients) exercise for that patient. 
The patients were instructed to exercise at this work load 
until symptomatic and unable to continue or until 20 minutes 
had elapsed, at which time the test was electively termi•
nated. Exercise hemodynamics and mixed venous blood for 
oxygen and lactate were sampled every 3 minutes while 
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Figure 1. The response in mixed venous lactate 
concentration and oxygen utilization (V02) in pa•
tients standing at rest and for each stage of exercise 
is shown (mean ± SD) for the five functional classes 
of patients with chronic heart failure. Classes A to 
E indicate heart failure of increasing severity from 
mild to very severe. Lactate production was con•
sidered present when mixed venous lactate concen•
tration exceeded 12 mg/lOO ml (dashed line). 
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respiratory gas exchange and the ventilatory response were 
monitored continuously. 
Statistical analysis. Patients were grouped on the basis 
of their V02 max and all combined results are presented as 
mean ± SD. Reproducibility was assessed by paired data 
analysis. For each patient and each level of exercise, in•
cluding values at rest, morning (AM) results were compared 
with afternoon (PM) data and day I with day 2. Pre-amrinone 
(control) and post-arnrinone (32 hour) results were com•
pared at each exercise stage with each patient serving as his 
or her own control. To ascertain whether, at any given level 
of work, there was a statistically significant difference in 
the hemodynamic response to exercise for the control period 
or after amrinone administration, a paired t test was used. 
Finally, comparisons of regression line slopes and intercepts 
were made using the method outlined by Brownlee (11). 
Submaximal aerobic and anaerobic exercise groups were 
compared at rest or at any given level of exercise using the 
one factor analysis of variance and the modified t statistic 
(12). Minimal acceptable significance for all statistical tests 
was a probability value less than 0.05/k, where k is the 
number of comparisons performed (12). 
Results 
Lactate production at rest and during incremental 
exercise. In four class D patients (severe heart failure), 
mixed venous lactate concentration at rest exceeded 12 mgllOO 
ml (range 12.5 to 18.1). The average cardiac output at rest, 
left ventricular filling pressure and oxygen extraction for 
these four patients was 1.49 ± 0.56 liters/min per m2 , 24 
± 5 mm Hg and 52 ± 8%, respectively. During incremental 
treadmill exercise their cardiac output increased to a max•
imum of only 2.09 ± 0.59 liters/min per m2 , whereas wedge 
pressure and oxygen extraction reached 33 ± 5 mm Hg and 
75 ± 6%, respectively; V02 max was 7.07 ± 1.43 mllmin 
per kg. Because oxygen delivery at rest was inadequate to 
sustain oxidative metabolism in these patients, we added 
another category, class E, to our classification of heart fail•
ure and considered these four patients as having very severe 
heart failure. 
In the remaining 59 patients, representing mild to severe 
heart failure, or classes A to D, anaerobic metabolism did 
not commence until oxygen demand had increased with 
exercise. The response in mixed venous lactate concentra•
tion as V02 increased with each stage of progressive tread•
mill exercise is shown for classes A to E in Figure 1. It is 
apparent that as the severity of heart failure increased, the 
onset of anaerobic metabolism, or anaerobic threshold (de•
fined as mixed venous lactate of greater than 12 mg/lOO 
ml) occurred at a progressively lower V02 • In classes A to 
D, the anaerobic threshold was 19.0 ± 4.4, 11.9 ± 3.3, 
9.3 ± 2.5 and 6.5 ± 2.0 mllmin per kg, respectively. In 
each class the V02 at the onset of anaerobiosis represented 
approximately 70% of V02 max. 
Reproducibility of lactate production during incre•
mental exercise. Same day. The responses of cardiac out•
put and mixed venous lactate concentration on the morning 
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test were quite reproducible when reexamined on the after•
noon of the same day in eight patients (one in class B, two 
in C, four in D and one in E) (Fig. 2). 
Next day. In all 20 patients receiving oral amrinone for 
32 hours (or four half-lives of the drug), the response of 
ventricular function to exercise was improved on the repeat 
exercise test. Left ventricular filling pressure was signifi•
cantly (p < 0.05) reduced at each stage of exercise while 
the response of exercise cardiac output was either similar 
to that of day 1 baseline in 8 patients (1 in class B, 3 in C 
and 4 in D) or significantly (p < 0.05) increased in 12 
Figure 2. Rest and exercise cardiac index and mixed venous lac•
tate concentration data obtained in the morning (AM) are compared 
with similar data obtained in the afternoon (PM) from the same 
patient. Reproducibility data from eight patients are presented. 
The solid line is the regression line with slope M, N is the number 
of data points and R is the correlation coefficient. Classes B to E 
designate the severity of heart failure (see text). This format is 
also used in Figures 3 and 4. 
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patients (1 in class B, 5 in C and 6 in D). These responses 
were then separated according to whether the exercise car•
diac output was increased or unchanged after amrinone 
administration. The cardiac output and lactate data for days 
1 and 2 are given for each of these responses to amrinone 
in Figures 3 and 4. It is apparent that with augmented sys•
temic blood flow during exercise (average increase of 9% 
or a slope of 1.09; upper panel, Fig. 3), lactate production 
was retarded on day 2 (lower panel) with the slope of 0.55 
being significantly (p < 0.05) less than that for the line of 
identity (slope = 1.00). The increase in mixed venous lac•
tate to greater than 12 mg/l 00 ml was delayed by at least 
one stage of exercise. In patients whose cardiac output re-
Figure 3. After 32 hours of amrinone therapy, the cardiac output 
response to exercise was significantly increased in 12 patients 
(slope 1.09; upper panel). The response in mixed venous con•
centration to exercise in these patients was improved in that lactate 
levels were lower after amrinone administration (slope 0.55; lower 
panel). Abbreviations as in Figure 2. 
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sponse to exercise was unchanged from baseline after am•
rinone administration (upper panel, Fig. 4), the lactate re•
sponse on day 2 (lower panel) was no different from that 
on day 1. 
Lactate production during aerobic and anaerobic en•
durance exercise. The five patients performing steady state 
(V02 ± 2%) aerobic endurance treadmill exercise were 
able to complete the full 20 minute protocol. The level of 
work represented 60 ± 3% of their V02 max. These patients 
experienced no symptoms of fatigue or breathlessness and 
their exercise was electively terminated. The average stand•
ing cardiac output of these patients was 2 .12 ± O. 31 liters/min 
per m2 , which increased to 3.90 ± 1.6 liters/min per m2 
during sub maximal exercise (Fig. 5). The standing rest to 
Figure 4. After 32 hours of amrinone therapy, the cardiac output 
response to exercise was unchanged in eight patients (upper panel). 
Their lactate response to exercise was also unchanged (lower panel). 
Abbreviations as in Figure 2. 
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Figure 5. The average hemodynamic and heart rate response to 
submaximal aerobic (five patients) and anaerobic (four patients) 
endurance exercise. Shown are standing rest data and data obtained 
at 3 minute intervals of constant level exercise for cardiac index 
(el), pulmonary wedge pressure (PCW), right atrial pressure (RAP) 
and heart rate (HR). 
end-exercise increases in wedge pressure (21 ± 5 to 36 ± 
8 mm Hg), heart rate (95 ± 17 to 117 ± 19 beats/min) 
and right atrial pressure (5 ± 4 to 10 ± 3 mm Hg) are also 
shown in Figure 5. Mixed venous lactate, which was 6.48 
± 3.06 mgllOO ml at rest, was unchanged during exercise 
(Fig. 6). From its level at rest of 17 ± 3 liters/min, minute 
ventilation increased to a steady state of 31 ± 6 liters/min 
with aerobic exercise (Fig. 6). Shown in Figure 7 are the 
components of the ventilatory response to aerobic endur•
ance, which consisted of a steady state increase in respi•
ratory rate from 22 ± 3 beats/min at rest to 28 ± 5 beats/min 
with exercise and tidal volume, which increased from 762 
± 181 ml at rest to 1,150 ± 170 mI with exercise. 
For the four patients who performed steady state anaer•
obic endurance exercise at 92 ± 4% of their V02 max, the 
hemodynamic response was not significantly different from 
that of their counterparts performing aerobic exercise (Fig. 
5). Cardiac output increased from 2.10 ± 0.17 liters/min 
per m2 at rest to 3.85 ± 0.21 liters/min per m2 with exercise; 
wedge pressure and right atrial pressure increased from 14 
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Figure 6. The response of mixed venous lactate concentration and 
minute ventilation (V E) during submaximal aerobic and anaerobic 
endurance exercise. 
± 11 and 7 ± 7 mm Hg at rest to 25 ± 6 and 12 ± 8 
mm Hg, respectively, with exercise. Heart rate was similarly 
increased from 87 ± 7 to 115 ± 12 beats/min with an•
aerobic exercise. A progressive increase in mixed venous 
lactate was seen with anaerobic endurance exercise. Figure 
6 depicts the increase in lactate that reached 26.39 ± 6.51 
mg/ 1 00 ml with anaerobic exercise from its level at rest of 
Figure 7. The response of tidal volume (VT) and respiratory rate 
(f) to submaximal aerobic and anaerobic endurance exercise. 
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5.70 ± 1. 38 mg/100 ml. Moreover, these patients expe•
rienced either dyspnea or fatigue as their dominant symp•
tom, which was perceived to be of sufficient severity to 
prematurely terminate (10.6 ± 3.8 minutes) the 20 minute 
endurance test. As a result of the progressive increase in 
lactate there was a different ventilatory response to exercise 
characterized by a progressive increase in minute ventilation 
(Fig. 6) from 13 ± 3 liters/min at rest to 44 ± llliters/min 
at end-exercise. The increase in minute ventilation was 
achieved by a steady increase in tidal volume from 682 ± 
64 to 1,470 ± 360 ml and a progressive increase in res•
piratory rate from 19 ± 3 beats/min at rest to 31 ± 4 
beats/min at end-exercise. 
Discussion 
During physical work, the oxygen requirements and car•
bon dioxide produced by muscle are both increased. Nor•
mally the ventilatory response does not limit the transfer of 
oxygen to hemoglobin or the elimination of carbon dioxide 
during maximal exercise (13,14); this is also true in patients 
with chronic heart failure (7). The heart, on the other hand, 
has a given capacity to deliver oxygenated blood to the 
metabolizing tissues. Maximal cardiac output, together with 
maximal oxygen extraction by the tissues and regional blood 
flow, determines the aerobic capacity of skeletal muscle. 
Because tissue oxygen extraction is not impaired in these 
patients (7), the response in cardiac output is central to 
regulating their aerobic capacity (7). In the absence of a 
training effect, where the distribution of blood flow or ox•
idative capacity of skeletal muscle may be increased (15) 
over many weeks of exercise, the anaerobic threshold will 
also be determined by exercise cardiac output. 
Oxygen delivery and anaerobic metabolism. We have 
previously demonstrated (7,16) that patients with heart dis•
ease have an abnormal augmentation in cardiac output re•
sponse to exercise. In fact, the maximal cardiac output at•
tained during exercise can be predicted by noninvasively 
determining the maximal oxygen uptake (\'02 max). Under 
these circumstances, when oxygen delivery is inadequate to 
satisfy the prevailing demand for oxygen, anaerobiosis be•
gins with a major shift of intracellular redox systems toward 
their reduced form. As a result, lactate production increases 
in working muscle, whether it is skeletal muscle (1-3) or 
the heart (17,18). The increase in blood lactic acid during 
exercise has been used to reflect such a defect in oxygen 
delivery to working skeletal muscle. As early as 1927, 
Meakins and Long (19) noted that during standing/running 
or walking the lactic acid concentration of peripheral venous 
blood was greater in patients with rheumatic mitral valve 
disease than in normal subjects. Moreover, in patients with 
very severe heart failure, venous lactate was increased at 
rest and increased even further with a deterioration of the 
patient's symptomatic failure and to an extent that corre-
JACC Vol. 6, No.4 
October 1985:717-24 
sponded with the severity of the circulatory impairment. 
Hallock (20) confirmed these findings during exercise with 
a chair ergometer in patients with valvular and congenital 
heart disease and also noted that the increase in venous lactic 
acid was most pronounced in the presence of a right to left 
shunt. 
In a large group of patients with rheumatic valvular heart 
disease, Donald et al. (4) demonstrated the profound levels 
of oxygen extraction achieved by working skeletal muscle 
and the increase in femoral vein lactate concentration as•
sociated with submaximal levels of supine leg exercise. 
They also observed that the more severe the impairment in 
exercise cardiac output, the earlier the onset of anaerobic 
metabolism. Similar observations were reported during up•
right ergometry by Wilson et al. (5) in patients with heart 
failure secondary to myopathic or ischemic heart disease. 
Thus, the severity of heart failure can effectively be graded 
by the appearance of anaerobic metabolism during exercise 
or, in extreme cases (for example, class E patients), at rest. 
We (7) previously confirmed the relation between the ap•
pearance of lactate production and aerobic capacity during 
upright treadmill exercise in patients with chronic heart fail•
ure of moderate to marked severity, as did Matsumura et 
al. (8). 
Reproducibility of the lactate response. In this study 
we have extended these observations to include mild and 
very severe heart failure. Moreover, we have indicated the 
reproducibility of the response in mixed venous lactate con•
centration during progressive upright exercise measured the 
same or next day and its relation to the response in exercise 
cardiac output. The present observations on anaerobic 
threshold determined from the increase in mixed venous 
lactate concentration greater than 12 mg/100 ml correlate 
with oUl' previously reported (7) findings using noninvasive 
respiratory gas exchange techniques. Irrespective of the se•
verity of heart failure, however, lactate production was ob•
served to begin when 60 to 70% of V02 max had been 
achieved. 
Lactate and alterations in oxygen delivery. In this study, 
the acute pharmacologic improvement in ventricular func•
tion and exercise cardiac output seen with arnrinone aug•
mented the aerobic capacity and delayed the appearance of 
anaerobic metabolism during exercise. Similar findings were 
reported by Siskind et al. (21). The improvement in oxygen 
delivery seen with dobutarnine (22,23) or hydralazine (24,25), 
however, has not been associated with an enhanced aerobic 
capacity or delayed lactate response. These latter findings 
can presumably be attributed to a shunting of blood away 
from working muscle that is secondary to the accompanying 
pharmacologic vasodilation. An improvement in aerobic ca•
pacity and presumably exercise cardiac output has also been 
observed after surgical treatment of mitral stenosis (26,27) 
and congenital heart disease (28). The long-term treatment 
of chronic heart failure with blockade of the postsynaptic 
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alpha receptor by trimazosin (9) has also been reported to 
be associated with a delay in the appearance of anaerobic 
metabolism, although here the additional influence of train•
ing may have been operative as a patient's functional status 
improved, permitting greater symptom-free physical activ•
ity. Training was shown to delay lactate production in both 
normal subjects (29) and patients with heart disease (15). 
However, we did not observe such a response in anaero•
biosis in long-term controlled trials where hydralazine (30) 
or the beta-adrenergic receptor agonist pirbuterol (31) was 
compared with placebo. Moreover, it is doubtful that an 
acute training response was operative in this study. 
Thus, the delay in anaerobic threshold observed in re•
sponse to any pharmacologic intervention will be based on 
a group of factors, including an improvement in systemic 
blood flow and specifically nutritive blood flow to working 
skeletal muscle, and the training response within skeletal 
muscle and its circulation. 
Lactate and the ventilatory response to sub maximal 
exercise. Our findings indicate that in patients with chronic 
stable heart failure of varying severity, submaximal aerobic 
endurance exercise of 20 minutes' duration is not accom•
panied by an increase in mixed venous lactate concentration. 
As a result, a steady state ventilatory response is observed 
and patients experience no sense of breathlessness or fa•
tigue. Similar findings were reported for normal subjects 
(3,32). The lack of objective and quantitative end points to 
submaximal aerobic exercise would appear to limit its use•
fulness in the evaluation of heart failure. In contrast, sub•
maximal anaerobic endurance exercise is associated with a 
progressive increase in venous lactate, a nonsteady state 
ventilatory response and the sensation of dyspnea in these 
patients. This type of sub maximal exercise may have clinical 
application to the evaluation of exertional dyspnea. In pa•
tients having previous carotid body resection for asthma, 
the ventilatory response to anaerobic exercise was much 
delayed and blunted (32). Thus, because exercise pulmonary 
venous pressure was not significantly different in both forms 
of submaximal exercise, it is tempting to speculate that the 
sensation of exertional dyspnea in patients with heart or 
circulatory failure is mediated through the carotid bodies 
and not from within the lung and its receptors. This view, 
however, remains to be tested. At least the appropriate ex•
ercise modality to evaluate ventilatory control in patients 
with heart failure is apparent. 
Limitations of the study. Finally, the limitations of the 
present study should be considered. We did not measure 
femoral vein lactate or the lactate concentration of leg mus•
cle. Their relation to the measurement of mixed venous 
lactate will have to be considered in future studies. This is 
particularly relevant to examining the issues of lactate pro•
duction, lactate release and lactate clearance in muscle and 
their relation to the anaerobic threshold determination. Our 
findings nevertheless strongly suggest that oxygen delivery 
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and availability are important factors in the overall process 
of lactate production that occurs during exercise in patients 
with chronic heart failure. In normal subjects other factors, 
such as skeletal muscle fiber type, capillary density or gly•
colytic enzyme composition (33), may be of greater im•
portance. Finally, the measurement of mixed venous lactate 
concentration used in this study may be more appropriate 
to examining the timing and the coupling of the ventilatory 
response to lactate production, given the presumptive role 
of the carotid bodies in mediating this response. 
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